Cargando…
Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
Metformin is currently the most prescribed drug for treatment of type 2 diabetes mellitus in humans. It has been well established that long-term treatment with metformin improves glucose tolerance in mice by inhibiting hepatic gluconeogenesis. Interestingly, a single dose of orally administered metf...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468119/ https://www.ncbi.nlm.nih.gov/pubmed/30992489 http://dx.doi.org/10.1038/s41598-019-42531-0 |